BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $45,073,000 | +55.8% | 43,774,000 | +60.0% | 0.01% | +40.0% |
| Q2 2018 | $28,930,000 | +40.1% | 27,363,000 | +35.1% | 0.01% | +25.0% |
| Q1 2018 | $20,656,000 | +30.5% | 20,253,000 | +38.4% | 0.00% | +33.3% |
| Q4 2017 | $15,832,000 | +6.2% | 14,634,000 | +9.6% | 0.00% | +50.0% |
| Q3 2017 | $14,901,000 | +85.3% | 13,357,000 | +84.0% | 0.00% | 0.0% |
| Q2 2017 | $8,043,000 | +130.3% | 7,258,000 | +134.7% | 0.00% | +100.0% |
| Q1 2017 | $3,492,000 | -32.3% | 3,092,000 | -32.9% | 0.00% | 0.0% |
| Q4 2016 | $5,155,000 | -55.6% | 4,610,000 | -52.3% | 0.00% | -66.7% |
| Q3 2016 | $11,599,000 | +50.4% | 9,671,000 | +39.3% | 0.00% | +50.0% |
| Q2 2016 | $7,711,000 | +33426.1% | 6,943,000 | +34615.0% | 0.00% | – |
| Q1 2016 | $23,000 | -99.7% | 20,000 | -99.7% | 0.00% | -100.0% |
| Q4 2015 | $8,764,000 | -34.2% | 6,820,000 | -33.8% | 0.00% | -33.3% |
| Q3 2015 | $13,314,000 | +23.2% | 10,306,000 | +47.0% | 0.00% | -25.0% |
| Q2 2015 | $10,804,000 | -30.7% | 7,010,000 | -33.1% | 0.00% | -20.0% |
| Q1 2015 | $15,594,000 | +4036.3% | 10,479,000 | +2771.0% | 0.01% | – |
| Q2 2014 | $377,000 | -86.6% | 365,000 | -85.8% | 0.00% | -100.0% |
| Q1 2014 | $2,808,000 | -40.4% | 2,563,000 | -42.4% | 0.00% | -50.0% |
| Q4 2013 | $4,714,000 | – | 4,450,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|